Catalyst Event
Regeneron Pharmaceuticals Inc (REGN) · Other
From Akros U.S. Large Cap 500 Index (AUL500)
4/13/2026, 12:00:00 AM
On April 13, 2026, the European Commission approved Dupixent (dupilumab) for the treatment of moderate-to-severe chronic spontaneous urticaria (CSU) in children aged two to 11
Korean Translation
2026년 4월 13일, 유럽 위원회의 2~11세 아동 대상 중등도-중증 만성 특발성 두드러기(CSU) 치료를 위한 듀피젠트 승인함
Related Recent Events
Cloudflare Inc (NET) · Other
Cloudflare is scheduled to host an Investor Day on June 9, 2026; a >=5% price impact is estimated as the company provides strategic updates scheduled.
6/9/2026, 12:00:00 AM
Chipotle Mexican Grill Inc (CMG) · Other
Shareholders approved a 50-for-1 stock split at the annual meeting on June 6, 2026. This major corporate action is expected to have a high price impact as it confirms the historic split scheduled.
6/6/2026, 12:00:00 AM
Hewlett Packard Enterprise Co (HPE) · Earnings Release
Q2 2026 earnings release is scheduled.
6/2/2026, 12:00:00 AM
Marvell Technology Inc (MRVL) · Earnings Release
First quarter fiscal year 2027 earnings results are scheduled to be released on May 29, 2026. Market impact is estimated at >1% as earnings releases typically drive volatility scheduled.
5/29/2026, 12:00:00 AM
Analog Devices Inc (ADI) · Earnings Release
Analog Devices is expected to release its fiscal second quarter 2026 financial results around late May. The date is estimated based on previous reporting schedules and is scheduled.
5/28/2026, 12:00:00 AM
Costco Wholesale Corp (COST) · Earnings Release
Third quarter fiscal 2026 earnings release, estimated to have a moderate impact on the stock price upon release, scheduled.
5/28/2026, 12:00:00 AM